| 732798 |
FRONTIERS IN ONCOLOGY |
Prognostic Factors for Overall Survival In Chronic Myeloid Leukemia Patients: A Multicentric Cohort Study by the Italian CML GIMEMA Network |
2021-08-26 |
10.3389/fonc.2021.739171 |
Specchia Giorgina, Pregno Patrizia, Breccia Massimo, Castagnetti Fausto, Monagheddu Chiara, Bonifacio Massimiliano, Tiribelli Mario, Stagno Fabio, Caocci Giovanni, Martino Bruno, Luciano Luigiana, Pizzuti Michele, Gozzini Antonella, Scortechini Anna Rita, Albano Francesco, Bergamaschi Micaela, Capodanno Isabella, Patriarca Andrea, Fava Carmen, Rege-Cambrin Giovanna, Sorà Federica, Galimberti Sara, Bocchia Monica, Binotto Gianni, Reddiconto Giovanni, DiTonno Paolo, Maggi Alessandro, Sanpaolo Grazia, De Candia Maria Stella, Giai Valentina, Abruzzese Elisabetta, Miggiano Maria Cristina, La Barba Gaetano, Pietrantuono Giuseppe, Guella Anna, Levato Luciano, Mulas Olga, Saccona Fabio, Rosti Gianantonio, Musto Pellegrino, Di Raimondo Francesco, Pane Fabrizio, Baccarani Michele, Saglio Giuseppe, Ciccone Giovannino |
| 732797 |
FRONTIERS IN ONCOLOGY |
Retraction: Ppm1b Negatively Regulates 3-Bromopyruvic Acid Induced Necroptosis in Breast Cancer Cells |
2021-08-26 |
10.3389/fonc.2021.757083 |
Frontiers Editorial Office |
| 732796 |
FRONTIERS IN ONCOLOGY |
Circulating microRNAs in Early Breast Cancer Patients and Its Association With Lymph Node Metastases |
2021-08-26 |
10.3389/fonc.2021.627811 |
Escuin Daniel, López-Vilaró Laura, Mora Josefina, Bell Olga, Moral Antonio, Pérez Ignacio, Arqueros Cristina, García-Valdecasas Bárbara, Ramón y Cajal Teresa, Lerma Enrique, Barnadas Agustí |
| 732795 |
FRONTIERS IN ONCOLOGY |
Is Adjuvant Chemotherapy Beneficial to All Patients With pT3N0M0 Stage Gastric Cancer? |
2021-08-26 |
10.3389/fonc.2021.712432 |
Huang Jiao-Bao, Lu Jun, Wu Dong, Xu Bin-bin, Xue Zhen, Lin Guo-Sheng, Zheng Hua-Long, Shen Li-li, Lin Jia, Xie Jian-Wei, Wang Jia-Bin, Lin Jian-Xian, Chen Qi-Yue, Cao Long-Long, Zheng Chao-Hui, Huang Chang-Ming, Li Ping |
| 732794 |
FRONTIERS IN ONCOLOGY |
Integrative Analysis Identified MCT4 as an Independent Prognostic Factor for Bladder Cancer |
2021-08-26 |
10.3389/fonc.2021.704857 |
Zhao Yang, Zhao Bin, Yan Wei-Hua, Xia Yan, Wang Zhi-Hui, Zheng Guo-Yang, Wang Wen-Da, Zhang Yu-Shi |
| 732793 |
FRONTIERS IN ONCOLOGY |
Pulmonary Toxicity After Total Body Irradiation – Critical Review of the Literature and Recommendations for Toxicity Reporting |
2021-08-26 |
10.3389/fonc.2021.708906 |
Vogel Jennifer, Hui Susanta, Hua Chia-Ho, Dusenbery Kathryn, Rassiah Premavarthy, Kalapurakal John, Constine Louis, Esiashvili Natia |
| 732792 |
FRONTIERS IN ONCOLOGY |
Exploration of the Potential Mechanism of Tao Hong Si Wu Decoction for the Treatment of Breast Cancer Based on Network Pharmacology and In Vitro Experimental Verification |
2021-08-26 |
10.3389/fonc.2021.731522 |
Huang Shi, Chen Yan, Pan Lingyu, Fei Changyi, Wang Ni, Chu Furui, Peng Daiyin, Duan Xianchun, Wang Yongzhong |
| 732791 |
FRONTIERS IN ONCOLOGY |
RhoC Modulates Cell Junctions and Type I Interferon Response in Aggressive Breast Cancers |
2021-08-26 |
10.3389/fonc.2021.712041 |
Abraham Hannah G., Ulintz Peter J., Goo Laura, Yates Joel A., Little Andrew C., Bao Liwei, Wu Zhifen, Merajver Sofia D. |
| 732790 |
FRONTIERS IN ONCOLOGY |
Integrated Bioinformatic Analysis of the Expression and Prognosis of Caveolae-Related Genes in Human Breast Cancer |
2021-08-26 |
10.3389/fonc.2021.703501 |
Tian Yao, Liu Xiaofeng, Hu Jing, Zhang Huan, Wang Baichuan, Li Yingxi, Fu Li, Su Ran, Yu Yue |
| 732789 |
FRONTIERS IN ONCOLOGY |
Association Between Efficacy of Immune Checkpoint Inhibitors and Sex: An Updated Meta-Analysis on 21 Trials and 12,675 Non-Small Cell Lung Cancer Patients |
2021-08-26 |
10.3389/fonc.2021.627016 |
Xue Chongxiang, Zheng Shuyue, Dong Huijing, Lu Xingyu, Zhang Xu, Zhang Jingyi, Li Jia, Cui Huijuan |
